Incidence of Anxiety in Parkinson's Disease During the Coronavirus Disease (COVID-19) Pandemic.
作者信息
Salari Mehri, Zali Alireza, Ashrafi Farzad, Etemadifar Masoud, Sharma Soumya, Hajizadeh Nastaran, Ashourizadeh Helia
机构信息
Functional Neurosurgery Research Center, Shohada Tajrish Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Functional Neurosurgery, Medical School, Isfahan University of Medical Science, Isfahan, Iran.
出版信息
Mov Disord. 2020 Jul;35(7):1095-1096. doi: 10.1002/mds.28116. Epub 2020 May 21.
Abstract
摘要
相似文献
1
Incidence of Anxiety in Parkinson's Disease During the Coronavirus Disease (COVID-19) Pandemic.冠状病毒病（COVID-19）大流行期间帕金森病患者焦虑症的发病率
Mov Disord. 2020 Jul;35(7):1095-1096. doi: 10.1002/mds.28116. Epub 2020 May 21.
2
Incidence of anxiety in epilepsy during coronavirus disease (COVID-19) pandemic.癫痫患者在冠状病毒病（COVID-19）大流行期间的焦虑发生率。
Epilepsy Behav. 2020 Nov;112:107442. doi: 10.1016/j.yebeh.2020.107442. Epub 2020 Sep 17.
3
One Aspect of Coronavirus disease (COVID-19) Outbreak in Iran: High Anxiety among MS Patients.冠状病毒病（COVID-19）在伊朗爆发的一个方面：多发性硬化症患者高度焦虑。
Mult Scler Relat Disord. 2020 Jun;41:102138. doi: 10.1016/j.msard.2020.102138. Epub 2020 Apr 20.
4
Mental Health, Physical Activity, and Quality of Life in Parkinson's Disease During COVID-19 Pandemic.新冠疫情期间帕金森病患者的心理健康、身体活动与生活质量
Mov Disord. 2020 Jul;35(7):1097-1099. doi: 10.1002/mds.28134. Epub 2020 Jun 7.
5
Anxiety Severity Levels and Coping Strategies during the COVID-19 Pandemic among People Aged 15 Years and Above in Gonabad, Iran.伊朗贡巴德地区 15 岁及以上人群在 COVID-19 大流行期间的焦虑严重程度和应对策略。
Arch Iran Med. 2020 Sep 1;23(9):633-638. doi: 10.34172/aim.2020.76.
6
Psychiatric symptoms related to the COVID-19 pandemic.与新冠疫情相关的精神症状。
Acta Neuropsychiatr. 2020 Oct;32(5):274-276. doi: 10.1017/neu.2020.24. Epub 2020 May 21.
7
Increased psychological well-being after the apex of the COVID-19 pandemic.在新冠疫情高峰期过后心理健康状况有所改善。
Acta Neuropsychiatr. 2020 Oct;32(5):277-279. doi: 10.1017/neu.2020.26. Epub 2020 Jul 6.
8
The depressive state of Denmark during the COVID-19 pandemic.新冠疫情期间丹麦的抑郁状况。
Acta Neuropsychiatr. 2020 Aug;32(4):226-228. doi: 10.1017/neu.2020.15. Epub 2020 Apr 22.
9
A Post-COVID-19 Parkinsonism in the Future?未来会出现新冠后帕金森综合征吗？
Mov Disord. 2020 Jul;35(7):1094. doi: 10.1002/mds.28117. Epub 2020 May 21.
10
Implementation of Telemedicine for Urgent and Ongoing Healthcare for Patients with Parkinson's Disease During the COVID-19 Pandemic: New Expectations for the Future.在2019冠状病毒病大流行期间为帕金森病患者提供紧急和持续医疗保健的远程医疗实施：对未来的新期望
J Parkinsons Dis. 2020;10(3):911-913. doi: 10.3233/JPD-202108.
引用本文的文献
1
Association between anxiety-depression status and psychological resilience in patients with Parkinson's disease: A risk factor analysis.帕金森病患者焦虑抑郁状态与心理弹性的相关性：一项危险因素分析。
World J Psychiatry. 2025 Aug 19;15(8):108704. doi: 10.5498/wjp.v15.i8.108704.
2
Perceived social support in the daily life of people with Parkinson's disease: a distinct role and potential classifier.帕金森病患者日常生活中的感知社会支持：独特作用与潜在分类指标
Sci Rep. 2025 Jul 24;15(1):26880. doi: 10.1038/s41598-025-12787-w.
3
The impact of the quarantine period due to the pandemic on the severity of Parkinson's disease and the quality of life of Parkinson's patients.疫情导致的隔离期对帕金森病严重程度及帕金森病患者生活质量的影响。
Clinics (Sao Paulo). 2025 Apr 23;80:100605. doi: 10.1016/j.clinsp.2025.100605. eCollection 2025.
4
Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer's, Parkinson's, and ALS.解读神经退行性变：阿尔茨海默病、帕金森病和肌萎缩侧索硬化症的分子机制与治疗进展综述
Int J Mol Sci. 2024 Nov 24;25(23):12613. doi: 10.3390/ijms252312613.
5
The relationship between COVID-19 anxiety and self-efficacy among adolescent students: A cross-sectional study.青少年学生中新冠焦虑与自我效能感的关系：一项横断面研究。
PLoS One. 2024 Dec 5;19(12):e0310434. doi: 10.1371/journal.pone.0310434. eCollection 2024.
6
The COVID-19 Pandemic and Its Influence on Patients With Myotonic Dystrophy Type 1: Lessons Learned.COVID-19 大流行及其对 1 型肌强直性营养不良患者的影响：经验教训。
Brain Behav. 2024 Nov;14(11):e70162. doi: 10.1002/brb3.70162.
7
Limited access to health care in patients with atypical parkinsonism during COVID-19 era may lead to higher mortality.在新冠疫情期间，非典型帕金森病患者获得医疗保健的机会有限，这可能导致更高的死亡率。
Curr J Neurol. 2022 Oct 7;21(4):256-258. doi: 10.18502/cjn.v21i4.11724.
8
Clinical features and outcomes of hospitalised patients with COVID-19 and Parkinsonian disorders: A multicentre UK-based study.COVID-19 住院患者与帕金森病患者的临床特征和转归：一项基于英国多中心的研究。
PLoS One. 2023 Jul 31;18(7):e0285349. doi: 10.1371/journal.pone.0285349. eCollection 2023.
9
Survey on the Impact of the COVID-19 Pandemic on Patients with Parkinson's Disease and Their Caregivers in Japan.关于新冠疫情对日本帕金森病患者及其照料者影响的调查
Patient Prefer Adherence. 2023 May 8;17:1221-1235. doi: 10.2147/PPA.S402193. eCollection 2023.
10
The impact of the COVID-19 pandemic on neuropsychiatric and sleep disorders, and quality of life in individuals with neurodegenerative and demyelinating diseases: a systematic review and meta-analysis of observational studies.COVID-19 大流行对神经退行性和脱髓鞘疾病患者的神经精神和睡眠障碍及生活质量的影响：观察性研究的系统评价和荟萃分析。
BMC Neurol. 2023 Apr 12;23(1):150. doi: 10.1186/s12883-023-03176-9.
本文引用的文献
1
Parkinson's Disease and COVID-19: Perceptions and Implications in Patients and Caregivers.帕金森病与2019冠状病毒病：患者及照料者的认知与影响
Mov Disord. 2020 Jun;35(6):912-914. doi: 10.1002/mds.28088. Epub 2020 May 8.
2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）和 2019 年冠状病毒病（COVID-19）：疫情和挑战。
Int J Antimicrob Agents. 2020 Mar;55(3):105924. doi: 10.1016/j.ijantimicag.2020.105924. Epub 2020 Feb 17.
3
Prevalence of Depression and Anxiety in Parkinson Disease and Impact on Quality of Life: A Community-Based Study in Spain.帕金森病中抑郁和焦虑的患病率及其对生活质量的影响：西班牙的一项社区研究。
J Geriatr Psychiatry Neurol. 2020 Jul;33(4):207-213. doi: 10.1177/0891988719874130. Epub 2019 Oct 9.
Zotero 插件